en

Sign up
Investments involve risks and are not suitable for all investors.

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Stock List・CytomX Therapeutics Inc
Search

CytomX Therapeutics Inc

Closed

Sector Healthcare

1.2 1.69

Buy

Price update 6 Sept 2024, 19:57 UTC

BuySell

Overview

Share price change

24h

Current

Min

1.19

Max

1.2

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+318.33 upside

Dividends

By Dow Jones

Next Earnings

5 Nov 2024

News Sentiment

By Acuity

50%

50%

94 / 365 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

1.1799 / 1.25 Support & Resistance

CytomX Therapeutics Inc Chart

Related News

11 Mar 2024, 22:55 UTC

Hot Stocks

Stocks to Watch: Oracle, Mission Produce, CytomX Therapeutics

DJ

Read

11 Mar 2024, 22:07 UTC

Earnings
Major Market Movers

CytomX Therapeutics Shares Fall 19% After Bristol Myers Squibb Decides Not to Continue Developing Candidate

DJ

Read

Peer Comparison

Price change

CytomX Therapeutics Inc Forecast

Price Target

By TipRanks

318.33% upside

12 Months Forecast

Average 5.02 USD  318.33%

High 8 USD

Low 3.5 USD

Based on 4 Wall Street analysts offering 12 month price targets forCytomX Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

4 ratings

2

Buy

2

Hold

0

Sell

Based on 4 analysts giving stock ratings to CytomX Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

1.1799 / 1.25Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Weak Bearish Evidence

Recent bearish events outweigh bullish events.

Long Term

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

94 / 365 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Other stocks from the sector

LLY

Eli Lilly and Co.

902.74

↓-0.9%

UNH

UnitedHealth Group Inc

596.8

↑ +0.31%

NVO

Novo Nordisk A-S

131.05

↑ +0.18%

JNJ

Johnson and Johnson

164.37

↓-0.29%

ABBV

AbbVie Inc

193.18

↑ +0.34%